{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:51:19Z","timestamp":1780393879245,"version":"3.54.1"},"reference-count":37,"publisher":"Walter de Gruyter GmbH","issue":"5","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s00005-020-00591-5","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T19:08:41Z","timestamp":1599764921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["IL-6 Contributes to the TGF-\u03b21-Mediated Epithelial to Mesenchymal Transition in Human Salivary Gland Epithelial Cells"],"prefix":"10.2478","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-1121","authenticated-orcid":false,"given":"Margherita","family":"Sisto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Ribatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Lisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"591_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/rheumatology\/34.4.326","volume":"34","author":"D Boumba","year":"1995","unstructured":"Boumba D, Skopouli FN, Moutsopoulos HM (1995) Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sj\u00f6gren's syndrome. Br J Rheumatol 34:326\u2013333","journal-title":"Br J Rheumatol"},{"key":"591_CR2","first-page":"965","volume":"15","author":"AA Drosos","year":"1988","unstructured":"Drosos AA, Andonopoulos AP, Costopoulos JS et al (1988a) Sj\u00f6gren's syndrome in progressive systemic sclerosis. J Rheumatol 15:965\u2013968","journal-title":"J Rheumatol"},{"key":"591_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/rheumatology\/27.2.123","volume":"27","author":"AA Drosos","year":"1988","unstructured":"Drosos AA, Andonopoulos AP, Costopoulos JS et al (1988b) Prevalence of primary Sj\u00f6gren's syndrome in an elderly population. Br J Rheumatol 27:123\u2013127","journal-title":"Br J Rheumatol"},{"key":"591_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","volume":"26","author":"DT Fisher","year":"2014","unstructured":"Fisher DT, Appenheimer MM, Evans SS (2014) The two faces of IL-6 in the tumor microenvironment. Semin Immunol 26:38\u201347","journal-title":"Semin Immunol"},{"key":"591_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2183\/pjab.86.717","volume":"86","author":"T Hirano","year":"2010","unstructured":"Hirano T (2010) Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir. Proc Jpn Acad Ser B Phys Biol Sci 86:717\u2013730","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"Suppl 1","key":"591_CR6","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/S0003-9969(99)90008-0","volume":"44","author":"MG Humphreys-Beher","year":"1999","unstructured":"Humphreys-Beher MG, Peck AB (1999) New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Arch Oral Biol 44(Suppl 1):S21\u2013S25","journal-title":"Arch Oral Biol"},{"key":"591_CR7","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3892\/mmr.2015.4706","volume":"13","author":"GX Jiang","year":"2016","unstructured":"Jiang GX, Cao LP, Kang PC et al (2016) Interleukin-6 induces epithelial-mesenchymal transition in human intrahepatic biliary epithelial cells. Mol Med Rep 13:1563\u20131569","journal-title":"Mol Med Rep"},{"key":"591_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1365-2249.2001.01500.x","volume":"124","author":"EK Kapsogeorgou","year":"2001","unstructured":"Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF et al (2001) Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sj\u00f6gren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 124:126\u2013133","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 2","key":"591_CR9","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar1916","volume":"8","author":"T Kishimoto","year":"2006","unstructured":"Kishimoto T (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 8(Suppl 2):S2","journal-title":"Arthritis Res Ther"},{"key":"591_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196","journal-title":"Nat Rev Mol Cell Biol"},{"key":"591_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jaut.2010.06.020","volume":"35","author":"S Lisi","year":"2010","unstructured":"Lisi S, Sisto M, Lofrumento DD et al (2010) Pro-inflammatory role of Anti-Ro\/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis. J Autoimmun 35:160\u2013170","journal-title":"J Autoimmun"},{"key":"591_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/labinvest.2011.190","volume":"92","author":"S Lisi","year":"2012","unstructured":"Lisi S, Sisto M, Lofrumento DD et al (2012) Sj\u00f6gren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE\/NF\u03baB. Lab Invest 92:615\u2013624","journal-title":"Lab Invest"},{"key":"591_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/emmm.200900043","volume":"1","author":"JM L\u00f3pez-Novoa","year":"2009","unstructured":"L\u00f3pez-Novoa JM, Nieto MA (2009) Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med 1:303\u2013314","journal-title":"EMBO Mol Med"},{"key":"591_CR14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.biopha.2018.09.177","volume":"108","author":"A Masjedi","year":"2018","unstructured":"Masjedi A, Hashemi V, Hojjat-Farsangi M et al (2018) The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer. Biomed Pharmacother 108:1415\u20131424","journal-title":"Biomed Pharmacother"},{"key":"591_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20110340","volume":"122","author":"M Mihara","year":"2012","unstructured":"Mihara M, Hashizume M, Yoshida H et al (2012) IL-6\/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci 122:143\u2013159","journal-title":"Clin Sci"},{"key":"591_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.7326\/0003-4819-92-2-212","volume":"92","author":"HM Moutsopoulos","year":"1980","unstructured":"Moutsopoulos HM, Chused TM, Mann DL et al (1980) Sjogren\u2019s syndrome (Sicca syndrome): current issues. Ann Intern Med 92:212\u2013226","journal-title":"Ann Intern Med"},{"key":"591_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA et al (2016) EMT: 2016. Cell 166:21\u201345","journal-title":"Cell"},{"key":"591_CR18","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","volume":"106","author":"N Nishimoto","year":"2005","unstructured":"Nishimoto N, Kanakura Y, Aozasa K et al (2005) Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106:2627\u20132632","journal-title":"Blood"},{"key":"591_CR19","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","volume":"29","author":"H Ogura","year":"2008","unstructured":"Ogura H, Murakami M, Okuyama Y et al (2008) Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29:628\u2013636","journal-title":"Immunity"},{"key":"591_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/jcb.21186","volume":"101","author":"DC Radisky","year":"2007","unstructured":"Radisky DC, Kenny PA, Bissell MJ (2007) Fibrosis and cancer: do myofibroblasts come also from epithelialcells via EMT? J Cell Biochem 101:830\u2013839","journal-title":"J Cell Biochem"},{"key":"591_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/ard.2004.025676","volume":"64","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Tzioufas AG, Font J (2005) Primary Sj\u00f6gren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 64:347\u2013354","journal-title":"Ann Rheum Dis"},{"key":"591_CR22","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1601-0825.2009.01582.x","volume":"15","author":"N Roescher","year":"2009","unstructured":"Roescher N, Tak PP, Illei GG (2009) Cytokines in Sj\u00f6gren's syndrome. Oral Dis 15:519\u2013526","journal-title":"Oral Dis"},{"key":"591_CR23","first-page":"559","volume":"52","author":"DA Sens","year":"1985","unstructured":"Sens DA, Hintz DS, Rudisill MT et al (1985) Explant culture of human submandibular gland epithelial cells: evidence for ductal origin. Lab Invest 52:559\u2013567","journal-title":"Lab Invest"},{"key":"591_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00418-010-0735-5","volume":"134","author":"M Sisto","year":"2010","unstructured":"Sisto M, Lisi S, Lofrumento DD et al (2010) Expression of pro-inflammatory TACE-TNF-\u03b1-amphiregulin axis in Sj\u00f6gren's syndrome salivary glands. Histochem Cell Biol 134:345\u2013353","journal-title":"Histochem Cell Biol"},{"key":"591_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00418-018-1680-y","volume":"150","author":"M Sisto","year":"2018","unstructured":"Sisto M, Lisi S, Ribatti D (2018a) The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands. Histochem Cell Biol 150:133\u2013147","journal-title":"Histochem Cell Biol"},{"key":"591_CR26","doi-asserted-by":"publisher","first-page":"1965935","DOI":"10.1155\/2018\/1965935","volume":"2018","author":"M Sisto","year":"2018","unstructured":"Sisto M, Lorusso L, Ingravallo G et al (2018b) The TGF-\u03b21 signaling pathway as an attractive target in the fibrosis pathogenesis of Sj\u00f6gren's syndrome. Mediators Inflamm 2018:1965935","journal-title":"Mediators Inflamm"},{"key":"591_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/cei.13337","volume":"198","author":"M Sisto","year":"2019","unstructured":"Sisto M, Lorusso L, Tamma R et al (2019) Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sj\u00f6gren's syndrome. Clin Exp Immunol 198:261\u2013272","journal-title":"Clin Exp Immunol"},{"key":"591_CR28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41374-020-0373-z","volume":"100","author":"M Sisto","year":"2020","unstructured":"Sisto M, Lorusso L, Ingravallo G et al (2020) TGF\u03b21-Smad canonical and - Erk non canonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sj\u00f6gren's syndrome. Lab Invest 100:824\u2013836","journal-title":"Lab Invest"},{"key":"591_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/1878-0261.12095","volume":"11","author":"M Suarez-Carmona","year":"2017","unstructured":"Suarez-Carmona M, Lesage J, Cataldo D et al (2017) EMT and inflammation: inseparable actors of cancer progression. Mol Oncol 11:805\u2013823","journal-title":"Mol Oncol"},{"key":"591_CR30","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/onc.2009.180","volume":"28","author":"NJ Sullivan","year":"2009","unstructured":"Sullivan NJ, Sasser AK, Axel AE et al (2009) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28:2940\u20132947","journal-title":"Oncogene"},{"key":"591_CR31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY et al (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871\u2013890","journal-title":"Cell"},{"key":"591_CR32","first-page":"4653","volume":"9","author":"M Trikha","year":"2003","unstructured":"Trikha M, Corringham R, Klein B et al (2003) Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence. Clin Cancer Res 9:4653\u20134665","journal-title":"Clin Cancer Res"},{"key":"591_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cyto.2014.05.024","volume":"70","author":"J Wolf","year":"2014","unstructured":"Wolf J, Rose-John S, Garbers C (2014) Interleukin-6 and its receptors: a highly regulated and dynamic system. Cytokine 70:11\u201320","journal-title":"Cytokine"},{"key":"591_CR34","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibroticdisease. Nat Med 18:1028\u20131040","journal-title":"Nat Med"},{"key":"591_CR35","first-page":"1171","volume":"40","author":"G Xie","year":"2012","unstructured":"Xie G, Yao Q, Liu Y et al (2012) IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures. Int J Oncol 40:1171\u20131179","journal-title":"Int J Oncol"},{"key":"591_CR36","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.7150\/ijbs.31999","volume":"15","author":"X Zheng","year":"2019","unstructured":"Zheng X, Lu G, Yao Y et al (2019) An autocrine IL-6\/IGF-1R loop mediates emt and promotes tumor growth in non-small cell lung cancer. Int J Biol Sci 15:1882\u20131891","journal-title":"Int J Biol Sci"},{"key":"591_CR37","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.3892\/mmr.2017.6538","volume":"15","author":"J Zhou","year":"2017","unstructured":"Zhou J, Zhang C, Pan J et al (2017) Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration. Mol Med Rep 15:4123\u20134131","journal-title":"Mol Med Rep"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-020-00591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-020-00591-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-020-00591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:28Z","timestamp":1704228568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-020-00591-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1007\/s00005-020-00591-5","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All the authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"27"}}